Eli Lilly’s much-anticipated obesity pill yields modest results Orforglipron led to 11% weight loss in late-stage trial, short of Zepbound and Wegovy

https://www.statnews.com/2025/08/07/eli-lilly-obesity-pill-orforglipron-modest-results/